Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers.
AbbVie has lost in an inter partes review (IPR) of its rheumatoid arthritis drug Humira.
Eli Lilly has been ordered by a district court to pay Germany-based company Erfindergemeinschaft UroPep $20 million for patent infringement.
McNair Law Firm has expanded its IP practice with the addition of John Johnson as a shareholder in the firm.
Medical device company ResMed has filed a motion to dismiss its International Trade Commission (ITC) complaint against New Zealand-based Fisher & Paykel.
Merck and Upsher-Smith Laboratories have agreed to pay $60.2 million in settlement fees to direct drug purchasers.
The European Commission has opened an investigation into multinational company Aspen Pharma over the price of five cancer drugs.
A California-based man has pleaded guilty to manufacturing counterfeit veterinary product labels.
The Senate of Canada has passed Bill C-30, which will change Canada’s pharma patent regulations including by allowing patent owners to recover patent term lost due to regulatory delays.
Medtronic has filed a motion to stay all deadlines and a notice of settlement in a patent dispute with medical device company Snyder Heart Valve.